Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended November 30, 1993, for National Medical Enterprises, Inc. (NME). The filing reflects a strategic pivot where the Company decided to discontinue its psychiatric hospital business and dispose of substantially all psychiatric and substance abuse facilities by May 31, 1994. Additionally, the Company sold 28 inpatient rehabilitation hospitals and 45 outpatient clinics in January 1994 to focus on its core general hospital business.
Key Financial Metrics
| Metric | Three Months Ended Nov 30, 1993 | Six Months Ended Nov 30, 1993 |
|---|---|---|
| Net Operating Revenues | $769,952,000 | $1,544,976,000 |
| Net Income (Loss) | $(226,191,000) | $(266,971,000) |
| Income from Continuing Operations | $61,180,000 | $113,908,000 |
| Cash Provided by Operating Activities | N/A | $109,627,000 |
| Cash and Cash Equivalents | $165,247,000 | $165,247,000 |
| Total Debt (Current + Long-Term) | $928,768,000 | $928,768,000 |
| Working Capital | $466,823,000 | $466,823,000 |
| Debt-to-Equity Ratio | 0.51:1 | 0.51:1 |
Material Changes vs. Prior Period
- Net Loss vs. Net Income: The Company reported a net loss of $226.2 million for the quarter, compared to net income of $52.4 million in the prior year quarter. This reversal was primarily driven by a $286.2 million charge for the estimated loss on disposal of the psychiatric business and operating losses from discontinued operations.
- Revenue Decline: Net operating revenues decreased 2% to $770.0 million for the quarter and 2% to $1.54 billion for the six-month period compared to the prior year. This decline was largely due to the divestiture of the psychiatric business and a 20% drop in "Other Businesses" revenue (primarily due to a change in accounting for the Westminster Health Care investment).
- Continuing Operations Performance: Excluding discontinued operations, income from continuing operations before taxes was $103.2 million for the quarter, down from $128.0 million in the prior year. Operating profits for continuing operations remained relatively stable, with a slight increase of $455,000 for the quarter.
- Legal Reserves: The Company recorded significant charges for unusual litigation costs, including a $65 million charge in the fourth quarter of fiscal 1993 and an additional $250 million reserve at August 31, 1993, related to insurance company lawsuits and psychiatric malpractice cases.
Guidance, Outlook, and Risks
- Divestiture Strategy: Management expects the disposal of the psychiatric business and the sale of rehabilitation hospitals (completed in January 1994 for approx. $260 million net proceeds) to significantly improve liquidity.
- Liquidity and Debt: The Company amended its $300 million credit agreement in September 1993 due to lender concerns regarding government investigations. The new agreement features higher interest rates (LIBOR + 1.75% to 2.25%) and more restrictive covenants, including limitations on dividends and capital expenditures.
- Credit Ratings: Standard & Poor's lowered the senior debt rating to BB in September 1993 but placed it on "CreditWatch" with positive implications in December. Moody's had previously lowered its rating to Baa-3.
- Legal Risks: Significant uncertainty remains regarding government investigations and remaining litigation. While settlements were reached with major insurance companies (totaling approx. $215 million) and 66 patient care lawsuits ($15 million), the ultimate liability for government investigations cannot be determined.
- Industry Outlook: The Company faces increased competition and payor pressure, including pre-admission authorization and a shift toward outpatient care. Managed care discounts are expected to continue rising.
Investor Verification Checklist
- Discontinued Operations Charge: Verify the $286.2 million charge for the psychiatric business divestiture and the assumptions regarding net realizable value.
- Legal Settlements: Confirm the final terms and payment schedules for the insurance company settlements ($125 million and $89.9 million) and the status of remaining government investigations.
- Debt Covenants: Review the specific restrictive covenants in the amended credit agreement, particularly regarding dividend restrictions and minimum operating ratios.
- Rehabilitation Sale Proceeds: Monitor the actual net cash proceeds from the January 1994 sale of rehabilitation hospitals, expected to be approximately $260 million.
- Continuing Operations Margins: Analyze the trend in operating profit margins for the core general hospital business, which declined slightly to 11.6% for the six-month period.